The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1564
ISSUE1564
January 28, 2019
OTC Primatene Mist Returns
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
OTC Primatene Mist Returns
January 28, 2019 (Issue: 1564)
The FDA has approved over-the-counter (OTC) sale
of inhaled epinephrine (Primatene Mist – Amphastar),
a nonselective alpha and beta agonist, for temporary
relief of mild symptoms of intermittent asthma in
patients ≥12 years old who have been...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.